| A Clinical Trial of PGDM1400 and PGT121 and VRC07-523LS Monoclonal Antibodies in HIV-infected and HIV-uninfected Adults (NCT03205917) | International AIDS Vaccine Initiative | 2017-10-23 |
| A Study of AK0529 to Evaluate Pharmacokinetics and Safety in Chinese Healthy Volunteers (NCT03322800) | Shanghai Ark Biopharmaceutical Co., Ltd. | 2017-10-23 |
| Comparative Bioavailability Study of Metformin/Sitagliptin 850 mg/50 mg Tablets in Healthy Male and Female Volunteers (NCT05549570) | Galenicum Health | 2017-10-22 |
| Study of CD19/CD22 Chimeric Antigen Receptor T Cells in Children & Young Adults w/ Recurrent or Refractory B Cell Malignancies (NCT03241940) | Stanford University | 2017-10-20 |
| Five Fraction SABR Dose Escalation for Early Stage Squamous Cell Carcinoma of the Lung (NCT03321747) | Indiana University | 2017-10-20 |
| A Study to Evaluate the Effect of Ibrutinib on the Pharmacokinetics of Oral Contraceptives, CYP2B6, and CYP3A4 Substrates in Female Participants With B Cell Malignancy (NCT03301207) | Janssen Research & Development, LLC | 2017-10-20 |
| A Study of AST-008 in Healthy Subjects (NCT03086278) | Exicure, Inc. | 2017-10-20 |
| Ketogenic Diet and Chemotherapy in Affecting Recurrence in Patients With Stage IV Breast Cancer (NCT03535701) | Ohio State University Comprehensive Cancer Center | 2017-10-20 |
| A Study of Ulocuplumab And Ibrutinib in Symptomatic Patients With Mutated CXCR4 Waldenstrom's Macroglobulinemia (NCT03225716) | Dana-Farber Cancer Institute | 2017-10-20 |
| A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Entecavir Extended Release (XR) in Healthy Subjects (NCT03239353) | Aucta Pharmaceuticals, Inc | 2017-10-20 |
| Effects of Liothyronine on Energy Expenditure and Cardiovascular Function (NCT03098433) | Virginia Commonwealth University | 2017-10-20 |
| Study to Evaluate the Safety and Efficacy of KITE-585 in Participants With Relapsed/Refractory Multiple Myeloma (NCT03318861) | Kite, A Gilead Company | 2017-10-20 |
| Safety and Exploratory Efficacy Study of UCMSCs in Patients With Alzheimer's Disease (NCT02672306) | South China Research Center for Stem Cell and Regenerative Medicine | 2017-10-20 |
| A Study to Assess the Safety, Tolerability, and Hemodynamic Response of PB1046 in Subjects With PAH (NCT03315507) | PhaseBio Pharmaceuticals Inc. | 2017-10-20 |
| Allogeneic Mesenchymal Human Stem Cells Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects (NCT02886884) | Joshua M Hare | 2017-10-20 |
| Phase 1 Study of Safety, Tolerability and Pharmacokinetics of SPR994 (NCT03395249) | Spero Therapeutics | 2017-10-20 |
| Phase I Clinical Trial in Chinese Patients of Advanced and (or) Recurrent Solid Tumor/Lymphoma (NCT03374007) | Genor Biopharma Co., Ltd. | 2017-10-19 |
| A Study of CPI-613 With Gemcitabine and Nab-paclitaxel for Patients With Advanced or Metastatic Pancreatic Cancer (NCT03435289) | Atlantic Health System | 2017-10-19 |
| Stem Cell Coated Fistula Plug in Patients With Crohn's RVF (NCT03220243) | Mayo Clinic | 2017-10-19 |
| A Phase Ia/Ib Study of CS1001 in Subjects With Advanced Solid Tumors (NCT03312842) | CStone Pharmaceuticals | 2017-10-19 |
| Clinical Trial Study About Human Adipose-Derived Stem Cells in the Stroke (NCT02813512) | Gwo Xi Stem Cell Applied Technology Co., Ltd. | 2017-10-19 |
| Javelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid Tumors (NCT03330405) | Pfizer | 2017-10-19 |
| Skin Irritation Potential of MOB015B in Healthy Subjects Using a Cumulative Irritant Patch Test Design (NCT06369675) | Moberg Pharma AB | 2017-10-19 |
| Bioavailability of DHE Administered by I123 POD Device, IV Injection, and Migranal Nasal Spray in Healthy Adults (NCT03401346) | Impel Pharmaceuticals | 2017-10-19 |
| Phase 1/2 Study to Evaluate the Safety and Efficacy of ATA188 in Subjects With Progressive Multiple Sclerosis (NCT03283826) | Atara Biotherapeutics | 2017-10-19 |
| Intraperitoneal Delivery of Adaptive Natural Killer (NK) Cells (FATE-NK100) With Intraperitoneal Int (NCT03213964) | Masonic Cancer Center, University of Minnesota | 2017-10-19 |
| Study of ORIC-101 in Healthy Adult Subjects (NCT03324555) | ORIC Pharmaceuticals | 2017-10-19 |
| Measuring Parkinson's Disease Progression (NCT03205956) | Kevin J. Black, MD | 2017-10-19 |
| CART-19 T Cell in CD19 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML) (NCT03896854) | Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd | 2017-10-18 |
| Comparison of Sotagliflozin Prototype Tablets With Reference Tablet in Healthy Subjects (NCT03310944) | Sanofi | 2017-10-18 |
| Ph I Trial of NAM NK Cells and IL-2 for Adult Pts With MM and NHL (NCT03019666) | Masonic Cancer Center, University of Minnesota | 2017-10-18 |
| A Study of Olaratumab (LY3012207), Doxorubicin, and Ifosfamide in Participants With Advanced or Metastatic Soft Tissue Sarcoma (NCT03283696) | Eli Lilly and Company | 2017-10-18 |
| An Investigational Study to Assess the Effect of BMS-986177 on Aspirin in Healthy Participants (NCT03341390) | Bristol-Myers Squibb | 2017-10-18 |
| Immunotherapy With Neo-adjuvant Chemotherapy for OVarian Cancer (NCT03249142) | ARCAGY/ GINECO GROUP | 2017-10-18 |
| Safety and Immunogenicity of pDNA Vaccines Expressing HIV M Group p24^Gag Conserved Elements and/or p55^Gag, Administered With IL-12 pDNA (NCT03181789) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-10-18 |
| A Study of Multiple Intravitreal Injection TK001 in Patients With Neovascular Age-related Macular Degeneration (NCT03021785) | Jiangsu T-Mab Biopharma Co.,Ltd | 2017-10-18 |
| A Phase 1 Study of HBI-3000 (NCT03397641) | HUYABIO International, LLC. | 2017-10-17 |
| Phase 1 Clinical Trial to Evaluate the Safety of Allogeneic NK Cell ("SMT-NK") Cell Therapy in Advanced Biliary Tract Cancer (NCT03358849) | Yonsei University | 2017-10-17 |
| Re-administration of Intramuscular AAV9 in Patients With Late-Onset Pompe Disease (NCT02240407) | University of Florida | 2017-10-17 |
| A Randomized, Open-label, Single-dose, Single-center, Crossover Study in Healthy Subjects to Assess the Relative Bioavailability of PT010 (NCT03311373) | Pearl Therapeutics, Inc. | 2017-10-17 |
| First In Human, Single Escalating Oral Dose Study Of PF-06882961 In Healthy Adult Subjects (NCT03309241) | Pfizer | 2017-10-17 |
| A Study in People With Normal Kidney Function and People With Reduced Kidney Function to Test How BI 1467335 is Processed in the Body (NCT03302091) | Boehringer Ingelheim | 2017-10-17 |
| A Study of Lasmiditan When Given With Sumatriptan in Healthy Participants (NCT03310411) | Eli Lilly and Company | 2017-10-17 |
| To Evaluate PK and Safety Profile of Oral MAD of Separately Using TG-2349, DAG181 or Combination in Healthy Chinese Volunteers (NCT03610880) | Dongguan HEC TaiGen Biopharmaceuticals Co., Ltd. | 2017-10-17 |
| This Study Tests a New Medicine Called BI 685509 in Patients That Have Kidney Problems Because of Diabetes. The Study Tests How BI 685509 is Taken up in the Body and How Well it is Tolerated (Multiple Rising Doses) (NCT03165227) | Boehringer Ingelheim | 2017-10-17 |
| A Food Effect Study of 60mg ER Torsemide (NCT03215875) | Sarfez Pharmaceuticals, Inc. | 2017-10-17 |
| Phase I, Pharmacokinetic, Safety and Tolerability Study in Healthy Volunteers (NCT03522012) | Mycenax Biotech Inc. | 2017-10-17 |
| First Time in Human (FTIH) Study to Evaluate Safety, Tolerability, Immunogenicity, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK3511294 Administered Subcutaneously (SC) in Subjects With Mild to Moderate Asthma (NCT03287310) | GlaxoSmithKline | 2017-10-17 |
| Evaluation of SAR408701 in Japanese Patients With Advanced Malignant Solid Tumors (NCT03324113) | Sanofi | 2017-10-17 |
| Single Ascending Dose Study of MEDI1341 in Healthy Volunteers (NCT03272165) | AstraZeneca | 2017-10-17 |
| Relative Bioavailability of BI 1015550 Following Oral Administration Under Fed and Fasted Conditions in Healthy Male Subjects (NCT03302078) | Boehringer Ingelheim | 2017-10-16 |
| Study of CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell (NCT03019055) | Medical College of Wisconsin | 2017-10-16 |
| Gene Transfer Clinical Trial for Mucopolysaccharidosis (MPS) IIIB (NCT03315182) | Abeona Therapeutics, Inc | 2017-10-16 |
| A Study to Evaluate SIMPONI (Golimumab) Therapy in Children, Adolescents and Young Adults With Pre-Symptomatic Type 1 Diabetes (NCT03298542) | Janssen Research & Development, LLC | 2017-10-16 |
| TNF-Inhibitor as Immune Checkpoint Inhibitor for Advanced MELanoma (NCT03293784) | Institut Claudius Regaud | 2017-10-16 |
| A Study of Lasmiditan in Healthy Participants When Co-administered With Topiramate (NCT03308669) | Eli Lilly and Company | 2017-10-16 |
| Study Evaluating Hemay022 in Combination With Endocrine Therapy In Subjects With ER Positive and HER2 Positive Advanced Breast Cancer (NCT03308201) | Tianjin Hemay Pharmaceutical Co., Ltd | 2017-10-16 |
| Study of Onivyde and 5-FU in Combination With Xilonix for Pancreatic Cancer With Cachexia (NCT03207724) | Andrew Hendifar, MD | 2017-10-16 |
| Research Study Investigating Study Medicine (NNC9204-1177) for Weight Management in People With Overweight or Obesity (NCT03308721) | Novo Nordisk A/S | 2017-10-16 |
| Study to Evaluate QR-110 in Leber's Congenital Amaurosis (LCA) Due to the c.2991+1655A>G Mutation (p.Cys998X) in the CEP290 Gene (NCT03140969) | Laboratoires Thea | 2017-10-16 |
| HDDO-1614 Bio Equivalence Study (NCT03382314) | Hyundai Pharmaceutical Co., LTD. | 2017-10-16 |
| A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-54767414 (Daratumumab) in Healthy Participants (NCT03320707) | Janssen Research & Development, LLC | 2017-10-16 |
| Pharmacokinetics Study of XG005 Capsule (NCT04499209) | Xgene Pharmaceutical Group | 2017-10-16 |
| Effect of Itraconazole on the Pharmacokinetics of Bardoxolone Methyl in Healthy Adults (NCT03264079) | Biogen | 2017-10-16 |
| Safety Evaluation of Cellavita HD Administered Intravenously in Participants With Huntington's Disease (NCT02728115) | Azidus Brasil | 2017-10-16 |
| Study to Evaluate the Sensitizing Potential of MOB015B in Healthy Subjects Using a Repeat Insult Patch Test Design (NCT06369727) | Moberg Pharma AB | 2017-10-15 |
| Peppermint Oil Pharmacokinetics/Dynamics and Novel Biological Signatures in Children With Functional Abdominal Pain (NCT03295747) | Robert Shulman, M.D. | 2017-10-15 |
| Evaluating the Infectivity, Safety, and Immunogenicity of a Respiratory Syncytial Virus Vaccine (RSV 6120/∆NS2/1030s) in RSV-Seropositive Children and RSV-Seronegative Infants and Children (NCT03387137) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-10-13 |
| Meclizine for Hepatocellular Carcinoma (NCT03253289) | Tannaz Armaghnay | 2017-10-13 |
| Adoptive Cell Therapy Across Cancer Diagnoses (NCT03296137) | Inge Marie Svane | 2017-10-13 |
| A Comparative Study of LY900014 to Insulin Lispro (Humalog) in Healthy Participants (NCT03286751) | Eli Lilly and Company | 2017-10-13 |
| Niraparib Plus Carboplatin in Patients With Homologous Recombination Deficient Advanced Solid Tumor Malignancies (NCT03209401) | Georgetown University | 2017-10-13 |
| Pharmacokinetics, Dialysability and Safety of P03277 in Healthy Volunteers and in Patients With Impaired Renal Function (NCT03657784) | Guerbet | 2017-10-13 |
| Study of Paclitaxel in Combination With BOS172722 in Patients With Advanced Nonhaematologic Malignancies (NCT03328494) | Boston Pharmaceuticals | 2017-10-13 |
| Study of TAS-102 Plus Radiation Therapy for the Treatment of the Liver in Patients With Hepatic Metastases From Colorectal Cancer (NCT03223779) | Massachusetts General Hospital | 2017-10-13 |
| DDI Study to Investigate the Impact of Itraconazole on the Pharmacokinetics of Dorzagliatin (NCT04080596) | Hua Medicine Limited | 2017-10-13 |
| A Study Assessing the PK, PD, Safety, and Tolerability of SB414 in Psoriasis (NCT03445013) | Novan, Inc. | 2017-10-13 |
| A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer (G/GEJ) or Esophageal Cancer (Morpheus-Gastric and Esophageal Cancer) (NCT03281369) | Hoffmann-La Roche | 2017-10-13 |
| Pharmacodynamic and Safety of MEDITOXIN® in Healthy Male Volunteers (NCT03317717) | Medy-Tox | 2017-10-12 |
| VM110 in Detection of Microscopic Tumors: A Phase I Study (NCT03286062) | Fox Chase Cancer Center | 2017-10-12 |
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS-MAPTRx in Patients With Mild Alzheimer's Disease (NCT03186989) | Ionis Pharmaceuticals, Inc. | 2017-10-12 |
| Study of Niraparib, TSR-022, Bevacizumab, and Platinum-Based Doublet Chemotherapy in Combination With TSR-042 (NCT03307785) | Tesaro, Inc. | 2017-10-12 |
| A Clinical Trial to Assess the Effects of Food on the Bioavailability of CKD-337 (NCT03382756) | Chong Kun Dang Pharmaceutical | 2017-10-12 |
| Safety and Efficacy of the ONCOlytic VIRus Armed for Local Chemotherapy, TG6002/5-FC, in Recurrent Glioblastoma Patients (NCT03294486) | Assistance Publique - Hôpitaux de Paris | 2017-10-12 |
| Study of the Pharmacokinetics of Trappsol and Effects on Potential Biomarkers of Niemann-Pick C1 (NPC1) (NCT02939547) | Cyclo Therapeutics, Inc. | 2017-10-11 |
| A Study of LY900014 in Participants With Type 2 Diabetes Mellitus (NCT03305822) | Eli Lilly and Company | 2017-10-11 |
| Magnesium And Verapamil After Recanalization in Ischemia of the Cerebrum: a Clinical and Translational Study. (NCT02912663) | Justin Fraser | 2017-10-11 |
| A Study to Compare the PK, PD and Safety and Tolerability of a SC With an IV Formulation of ARGX-113 in Healthy Male Subjects (NCT03334084) | argenx | 2017-10-11 |
| Nivolumab and Tumor Infiltrating Lymphocytes (TIL) in Advanced Non-Small Cell Lung Cancer (NCT03215810) | H. Lee Moffitt Cancer Center and Research Institute | 2017-10-11 |
| Phase 1 Study of ELX-02 in Healthy Adult Subjects (NCT03309605) | Eloxx Pharmaceuticals, Inc. | 2017-10-11 |
| Hepatic Transarterial Administrations of NKR-2 in Patients With Unresectable Liver Metastases From Colorectal Cancer (NCT03370198) | Celyad Oncology SA | 2017-10-11 |
| Pharmacokinetics and Tolerancebility Studies of Gentuximab Injection in the Treatment ofPatients With Late Recurrence of Metastatic Solid Tumors in China (NCT03313219) | Changchun GeneScience Pharmaceutical Co., Ltd. | 2017-10-11 |
| A Safety and Pharmacokinetic (PK) Study of GSK2982772 in Healthy Subjects (NCT03305419) | GlaxoSmithKline | 2017-10-11 |
| Liposomal Bupivacaine vs Bupivacaine for Pain Control After Sternotomy (NCT04585867) | University of Kansas Medical Center | 2017-10-11 |
| Astra Zeneca (Immuno Stereotactic Ablative Body Radiotherapy) ISABR Study: Randomized Phase I/II Study of Stereotactic Body Radiotherapy (NCT03148327) | Jonsson Comprehensive Cancer Center | 2017-10-11 |
| AZD5363 in Patients With Advanced Solid Tumors Harboring AKT Mutations (NCT03310541) | Memorial Sloan Kettering Cancer Center | 2017-10-11 |
| A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer (NCT03288545) | Astellas Pharma Global Development, Inc. | 2017-10-11 |
| AZD1390 Administration of a Microdose [11C]AZD1390 to Healthy Volunteers (NCT03215381) | AstraZeneca | 2017-10-10 |
| The Safety and Tolerability, Pharmacokinetics of TNP-2092 Capsules in Combination With Rabeprazole Sodium Enteric-coated Tablets (NCT06337604) | TenNor Therapeutics Inc. | 2017-10-10 |
| Pre-operative Mocetinostat (MGCD0103) and Durvalumab (MEDI4736) (PRIMED) for Squamous Cell Carcinoma of the Oral Cavity (NCT02993991) | University Health Network, Toronto | 2017-10-10 |